Literature DB >> 28063733

Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.

Kim Dao1, Haithem Chtioui2, Yimin Lu2, Cody J Peer3, William D Figg3, Menno Pruijm2, Thierry Buclin2, Sébastien Kissling2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28063733      PMCID: PMC6667183          DOI: 10.1053/j.ajkd.2016.10.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  2 in total

1.  In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects.

Authors:  Yan Li; Liangang Liu; Xiaomin Wang; Chengyue Zhang; Josephine Reyes; Matthew Hoffmann; Maria Palmisano; Simon Zhou
Journal:  J Clin Pharmacol       Date:  2018-05-15       Impact factor: 3.126

2.  An Open-Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics.

Authors:  Yan Li; Xiaomin Wang; Liangang Liu; Chengyue Zhang; Diana Gomez; Josephine Reyes; Maria Palmisano; Simon Zhou
Journal:  Clin Pharmacol Drug Dev       Date:  2018-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.